The Court Ruled, "Daewoong Acquired ‘Nabota' Illegally”…Medy Tox 'Wins' in the 1st Civil Court Case 
The Court Ruled, "Daewoong Acquired ‘Nabota' Illegally”…Medy Tox 'Wins' in the 1st Civil Court Case 
  • Cho Pil Hyun, Staff Reporter
  • 승인 2023.02.13 09:52
  • 수정 2023.02.13 09:52
  • 댓글 0
이 기사를 공유합니다

Verdict of 40 billion won damage compensation for "unlawful acquisition of strains and manufacturing process trade secrets"
Medy Tox, “Justice and fairness have prevailed again”
[Photo courtesy of Medy Tox]
[Photo courtesy of Medy Tox]

The Seoul Central District Court on February 10 ruled in favor of Medy Tox in the first trial of a civil lawsuit alleging that Daewoong Pharmaceutical (Daewoong) illegally acquired Medy Tox's strains and manufacturing process trade secrets.

The court's 61st Civil Division (Deputy Chief Judge Kwon Oh-Seok) ruled, "Daewoong's 'Nabota' was developed through stealing Medy Tox's botulinum strain and manufacturing process,".

The court banned the manufacture and sale of Daewoong's botulinum toxin products, including Nabota, and ordered the surrender of the strains and the destruction of the toxin formulations already produced.

The court also ordered Daewoong to pay out 40 billion won to Medy Tox as compensate for damages.

In relation to this, Medy Tox explained that the judge found that the strain used by Daewoong to produce botulinum toxin was derived from Medy Tox's strain and the claim that it was isolated and identified from domestic soil was difficult to believe in light of the evidence.

The company added that the judge saw that the manufacturing process used to produce botulinum toxin was developed based on an illegally acquired manufacturing process by Daewoong, and the claim that it had been independently developed was difficult to believe based on the excessively short development period and development records.

An official from Medy Tox said, "The court's decision is a clear judgment based on irrefutable scientific evidence including genome sequencing, and we are very pleased to see that justice and fairness are alive and well in Korea.".

Medy Tox won in the court case 5 years and 4 months after filing a lawsuit against Daewoong in the Seoul Central District Court in October 2017, alleging that its botulinum strain and manufacturing process were stolen.

[WIKI KOREA=Cho Pil Hyun, Staff Reporter]

chop23@wikileaks-kr.org


  • 서울특별시 마포구 마포대로 127, 1001호 (공덕동, 풍림빌딩)
  • 대표전화 : 02-702-2677
  • 팩스 : 02-702-1677
  • 청소년보호책임자 : 소정원
  • 법인명 : 위키리크스한국 주식회사
  • 제호 : 위키리크스한국
  • 등록번호 : 서울 아 04701
  • 등록일 : 2013-07-18
  • 발행일 : 2013-07-18
  • 발행인 : 박정규
  • 편집인 : 박찬흥
  • 위키리크스한국은 자체 기사윤리 심의 전문위원제를 운영합니다.
  • 기사윤리 심의 : 박지훈 변호사
  • 위키리크스한국 모든 콘텐츠(영상,기사, 사진)는 저작권법의 보호를 받은바, 무단 전재와 복사, 배포 등을 금합니다.
  • Copyright © 2024 위키리크스한국. All rights reserved.
  • [위키리크스한국 보도원칙] 본 매체는 독자와 취재원 등 뉴스 이용자의 권리 보장을 위해 반론이나 정정보도, 추후보도를 요청할 수 있는 창구를 열어두고 있음을 알립니다.
    고충처리 : 02-702-2677 | 메일 : laputa813@wikileaks-kr.org
ND소프트